Effect of renal impairment on the pharmacokinetics of rosiglitazone (RSG)

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 2, 1999, Pages 185-

  Chapelsky, M C ^a   Thompson, K ^b   Miller, A ^a   Sack, M ^c   Blum, R ^d   Jorkasky, D ^b   Freed, M I ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Presbyt Clinical Pharmacology Unit   (United States)

^c Center for Clinical Research   (United States)

^d SmithKline Beecham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0010417876     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)80273-2     Document Type: Article

References (0)